2305627
Project Grant
Overview
Grant Description
SBIR Phase I: A soft, tip-growing, self-deploying endotracheal tube that enables visualization-free intubation - The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is a novel technology that actively intubates airway passages while reducing the risks of complications arising from difficult or failed emergency procedures.
Such a procedure is often used with patients suffering from trauma, hypoxia, or cardiac arrest. The proposed soft robotic device extends from its tip, imbued with active mechanical intelligence to autonomously navigate the upper airway enabling visualization-free self-deployment. The proposed technology contrasts with current semi-rigid devices, which are pushed from the proximal base of the device by the user.
This project aims to improve intubation success rates, reduce complications, and mitigate system-wide costs associated with failed airway management. Furthermore, the technology aims to reduce the navigation and placement skill sets needed to intubate patients, enabling the potential option for field personnel to safely and readily provide airway management.
The product aims to capture a portion of the $2 billion annual global airway devices market, ultimately expanding the market through greater user adoption and use case options. This Small Business Innovation Research (SBIR) Phase I project aims to demonstrate proof of concept for a self-deploying intubation device.
A soft robotics system will be developed that aims to achieve a >90% first-pass intubation success rate. The technical measures include deploying at an effective pressure (<20KPA), in a rapid manner (15S), with comparable forces to the tissue (<15N) as expert-guided laryngoscopes, agnostic to user skill sets.
During Phase I, design and engineering will be furthered to enable feasibility testing and product validation. The design will be optimized for efficacy, safety, and speed via iterative cadaver testing. Completion of this project will yield an operational, tip-growing, soft robotic prototype for airway intubation accounting for human variability.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria. Subawards are not planned for this award.
Such a procedure is often used with patients suffering from trauma, hypoxia, or cardiac arrest. The proposed soft robotic device extends from its tip, imbued with active mechanical intelligence to autonomously navigate the upper airway enabling visualization-free self-deployment. The proposed technology contrasts with current semi-rigid devices, which are pushed from the proximal base of the device by the user.
This project aims to improve intubation success rates, reduce complications, and mitigate system-wide costs associated with failed airway management. Furthermore, the technology aims to reduce the navigation and placement skill sets needed to intubate patients, enabling the potential option for field personnel to safely and readily provide airway management.
The product aims to capture a portion of the $2 billion annual global airway devices market, ultimately expanding the market through greater user adoption and use case options. This Small Business Innovation Research (SBIR) Phase I project aims to demonstrate proof of concept for a self-deploying intubation device.
A soft robotics system will be developed that aims to achieve a >90% first-pass intubation success rate. The technical measures include deploying at an effective pressure (<20KPA), in a rapid manner (15S), with comparable forces to the tissue (<15N) as expert-guided laryngoscopes, agnostic to user skill sets.
During Phase I, design and engineering will be furthered to enable feasibility testing and product validation. The design will be optimized for efficacy, safety, and speed via iterative cadaver testing. Completion of this project will yield an operational, tip-growing, soft robotic prototype for airway intubation accounting for human variability.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria. Subawards are not planned for this award.
Awardee
Funding Goals
THE GOAL OF THIS FUNDING OPPORTUNITY, "NSF SMALL BUSINESS INNOVATION RESEARCH (SBIR)/ SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAMS PHASE I", IS IDENTIFIED IN THE LINK: HTTPS://WWW.NSF.GOV/PUBLICATIONS/PUB_SUMM.JSP?ODS_KEY=NSF22551
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Santa Barbara,
California
93106-6105
United States
Geographic Scope
Single Zip Code
Related Opportunity
22-551
Vine Medical was awarded
Project Grant 2305627
worth $274,440
from National Science Foundation in September 2023 with work to be completed primarily in Santa Barbara California United States.
The grant
has a duration of 5 months and
was awarded through assistance program 47.084 NSF Technology, Innovation, and Partnerships.
SBIR Details
Research Type
SBIR Phase I
Title
SBIR Phase I:A Soft, Tip-Growing, Self-Deploying Endotracheal Tube that Enables Visualization-Free Intubation
Abstract
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase I project is a novel technology that actively intubates airway passages while reducing the risks of complications arising from difficult or failed emergency procedures.Such a procedure is often used with patients suffering from trauma, hypoxia, or cardiac arrest. The proposed soft robotic device extends from its tip, imbued with active mechanical intelligence to autonomously navigate the upper airway enabling visualization-free self-deployment.The proposed technology contrasts with current semi-rigid devices, which are pushed from the proximal base of the device by the user. This project aims to improve intubation success rates, reduce complications, and mitigate system-wide costs associated with failed airway management. Furthermore, the technology aims to reduce the navigation and placement skill sets needed to intubate patients, enabling the potential option for field personnel to safely and readily provide airway management. The product aims to capture a portion of the $2 billion annual global airway devices market, ultimately expanding the market through greater user adoption and use case options._x000D_ _x000D_ This Small Business Innovation Research (SBIR) Phase I project aims to demonstrate proof of concept for a self-deploying intubation device. A soft robotics system will be developed that aims to achieve a greater than90% first-pass intubation success rate. The technical measures include deploying at an effective pressure (less than20kPa), in a rapid manner (15s), with comparable forces to the tissue (less than15N) as expert-guided laryngoscopes, agnostic to user skill sets. During Phase I, design and engineering will be furthered to enable feasibility testing and product validation.The design will be optimized for efficacy, safety, and speed via iterative cadaver testing. Completion of this project will yield an operational, tip-growing, soft robotic prototype for airway intubation accounting for human variability._x000D_ _x000D_ This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
Topic Code
MD
Solicitation Number
NSF 22-551
Status
(Complete)
Last Modified 9/5/23
Period of Performance
9/1/23
Start Date
2/29/24
End Date
Funding Split
$274.4K
Federal Obligation
$0.0
Non-Federal Obligation
$274.4K
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
2305627
SAI Number
None
Award ID URI
SAI EXEMPT
Awardee Classifications
Small Business
Awarding Office
491503 TRANSLATIONAL IMPACTS
Funding Office
491503 TRANSLATIONAL IMPACTS
Awardee UEI
ZVQZCERRR853
Awardee CAGE
95NU4
Performance District
CA-24
Senators
Dianne Feinstein
Alejandro Padilla
Alejandro Padilla
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Research and Related Activities, National Science Foundation (049-0100) | General science and basic research | Grants, subsidies, and contributions (41.0) | $274,440 | 100% |
Modified: 9/5/23